Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03289910
Title Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

atypical chronic myeloid leukemia, BCR-ABL1 negative

myelofibrosis

myelodysplastic/myeloproliferative neoplasm

acute myeloid leukemia

chronic myelomonocytic leukemia

essential thrombocythemia

myeloproliferative neoplasm

Therapies

Carboplatin + Topotecan + Veliparib

Carboplatin + Topotecan

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Los Angeles County-USC Medical Center Los Angeles California 90033 United States Details
USC / Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
USC Norris Oncology/Hematology-Newport Beach Newport Beach California 92663 United States Details
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21287 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field